Felipe Duran
Förmögenhet: 68 351 $ per 2026-05-31
Förmögenhet: 68 351 $ per 2026-05-31
Felipe Duran is currently Chief Financial Officer at iBio, Inc. since 2023.
Formerly, Mr. Duran was Chief Financial Officer-Lupin Latin America at Lupin Pharmaceuticals, Inc. from 2016 to 2021 and Manager-Financial Planning & Analysis at Noven Pharmaceuticals, Inc. Education includes undergraduate and MBA degrees from the University of Miami.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IBIO, INC. 0,1 % | 2026-03-19 | 35 974 ( 0,1 % ) | 68 351 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| IBIO, INC. | Finansdirektör/CFO | 2023-02-13 |
| Företag | Position | Slut |
|---|---|---|
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Finansdirektör/CFO | 2021-05-01 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån